Publication | Closed Access

Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002)

Surgical OncologyOxaliplatin Plus CetuximabHepatologyPhase Ii TrialGastrointestinal OncologyMedicineColorectal CancerPathologyColorectal Cancer PatientsLiver CancerOncologyRadiation Oncology